Skip to main content

opioid crisis

By Jessica Hagen | 01:54 pm | September 27, 2022
  The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance.  
HIMSS22
By Emily Olsen | 11:35 am | February 03, 2022
In a preview of their HIMSS22 session, Kasey Claborn of the University of Texas and Andrea L. Daugherty from the Dell Medical School explain how better overdose surveillance could improve response and outreach.
By Emily Olsen | 12:47 pm | September 16, 2021
The study also found patients in the 24-week group had a 27% decrease in unique hospital encounters compared with the group who only received one prescription.
By Sofia Noori and Dan Gebremedhin | 11:59 am | June 12, 2020
Flare Capital Partners reviews the current landscape of substance use disorder treatment and highlights some early-stage tech companies tackling the ongoing opioid epidemic.
By Dave Muoio | 01:04 pm | March 02, 2020
The company formerly focused its efforts on enabling chronic pain management care.
By Laura Lovett | 05:03 pm | February 10, 2020
The company plans to triple its production, design and engineering teams with the new funds. 
By Jonah Comstock | 11:57 am | February 11, 2019
Geisinger CIO Karen Murphy says complexity in healthcare can hide providers’ underlying empathy.
By Jonah Comstock | 04:10 pm | January 31, 2019
Duke University has received about $500K out of a $2M multifaceted investment from Blue Cross Blue Shield of North Carolina to battle the opioid epidemic.
By Laura Lovett | 01:16 pm | October 25, 2018
Trump invited 21 companies to the White House signing of the bill, including Amazon, which unveiled a new AWS Opioid Crisis Council. 
By Dave Muoio | 05:04 pm | October 19, 2018
The app offers users a stronger recovery support network while helping care teams track and flag those at risk for relapse.